These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis. Aharoni R, Saada R, Eilam R, Hayardeny L, Sela M, Arnon R. J Neuroimmunol; 2012 Oct 15; 251(1-2):14-24. PubMed ID: 22749337 [Abstract] [Full Text] [Related]
3. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. Furlan R, Kurne A, Bergami A, Brambilla E, Maucci R, Gasparini L, Butti E, Comi G, Ongini E, Martino G. J Neuroimmunol; 2004 May 15; 150(1-2):10-9. PubMed ID: 15081244 [Abstract] [Full Text] [Related]
12. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q. J Neuroimmunol; 2009 Jan 03; 206(1-2):58-69. PubMed ID: 19081144 [Abstract] [Full Text] [Related]
14. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. Peron JP, Yang K, Chen ML, Brandao WN, Basso AS, Commodaro AG, Weiner HL, Rizzo LV. J Neuroimmunol; 2010 Oct 08; 227(1-2):10-7. PubMed ID: 20580440 [Abstract] [Full Text] [Related]